STRIPPOLI, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 14.755
AS - Asia 1.336
EU - Europa 1.188
SA - Sud America 19
OC - Oceania 14
AF - Africa 6
Totale 17.318
Nazione #
US - Stati Uniti d'America 14.737
CN - Cina 781
SE - Svezia 463
SG - Singapore 448
GB - Regno Unito 171
IT - Italia 107
DE - Germania 102
UA - Ucraina 83
FI - Finlandia 57
BE - Belgio 56
IN - India 49
FR - Francia 33
IE - Irlanda 25
NL - Olanda 17
AU - Australia 14
IL - Israele 14
BR - Brasile 12
CA - Canada 12
ES - Italia 8
HK - Hong Kong 8
JP - Giappone 8
CZ - Repubblica Ceca 6
RO - Romania 6
VN - Vietnam 6
CH - Svizzera 5
HU - Ungheria 5
ME - Montenegro 4
RU - Federazione Russa 4
TW - Taiwan 4
AR - Argentina 3
AT - Austria 3
BG - Bulgaria 3
IR - Iran 3
MK - Macedonia 3
PA - Panama 3
PT - Portogallo 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
DK - Danimarca 2
EC - Ecuador 2
HR - Croazia 2
IM - Isola di Man 2
LT - Lituania 2
MA - Marocco 2
MY - Malesia 2
NO - Norvegia 2
PH - Filippine 2
PL - Polonia 2
SA - Arabia Saudita 2
TH - Thailandia 2
AL - Albania 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CR - Costa Rica 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
ID - Indonesia 1
JM - Giamaica 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
NG - Nigeria 1
NP - Nepal 1
SC - Seychelles 1
SI - Slovenia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 17.318
Città #
Fairfield 2.695
Chandler 1.530
Woodbridge 1.364
Ashburn 1.333
Houston 1.172
Seattle 1.131
Cambridge 1.123
Wilmington 877
Ann Arbor 409
Nyköping 383
Beijing 312
Lawrence 298
Roxbury 294
Singapore 286
Des Moines 212
Jacksonville 201
New York 123
San Diego 113
Inglewood 106
Dearborn 98
Nanjing 74
Santa Clara 61
Brussels 56
Falls Church 46
Los Angeles 44
Washington 43
London 39
Boardman 35
Pune 33
Hefei 29
Princeton 26
Dublin 25
Edinburgh 25
Bari 24
Guangzhou 23
Kunming 22
Munich 22
Hebei 20
Nanchang 19
Paris 19
Brooklyn 18
Jinan 18
Helsinki 17
Redwood City 17
Jiaxing 16
Kilburn 16
Changsha 15
Shanghai 14
Hounslow 13
Shenyang 13
Wuhan 13
Amsterdam 12
Hadera 11
Tianjin 11
Zhengzhou 11
Chicago 10
San Francisco 10
San Mateo 9
Stockholm 9
Prescot 8
Rome 8
Tokyo 8
Madrid 7
Toronto 7
Dong Ket 6
Prague 6
Sydney 6
Atlanta 5
Augusta 5
Hong Kong 5
Jinhua 5
Milan 5
New Bedfont 5
New Delhi 5
Wandsworth 5
Auburn Hills 4
Budapest 4
Chengdu 4
Frankfurt am Main 4
Norwalk 4
Podgorica 4
Rockhampton 4
Shenzhen 4
Xian 4
Acton 3
Belgrade 3
Chongqing 3
Dalian 3
Hangzhou 3
Islington 3
Las Vegas 3
Lisbon 3
Marseille 3
Messina 3
Miami 3
Ningbo 3
Panama City 3
Sofia 3
Taichung 3
Taranto 3
Totale 15.178
Nome #
The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial 146
A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study 144
Catheter-related interventions to prevent peritonitis in peritoneal dialysis: A systematic review of randomized, controlled trials 132
Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop 126
An "evidence-based" survey of therapeutic options for IgA nephropathy: assessment and criticism 118
Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn's Disease: A Systematic Review of Randomized Trials 113
HMG CoA reductase inhibitors (statins) for kidney transplant recipients 108
Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease 108
Prevalence and correlates of erectile dysfunction in men on chronic haemodialysis: a multinational cross-sectional study 106
Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease: A Systematic Review and Meta-analysis 98
Addition of the Multidimensional Prognostic Index to the Estimated Glomerular Filtration Rate Improves Prediction of Long-Term All-Cause Mortality in Older Patients with Chronic Kidney Disease 96
Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials 92
How to read critically a prognostic cohort study 91
Clinician beliefs and attitudes about home haemodialysis: A multinational interview study 91
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials 91
Primary cerebral lymphoma and membranous nephropathy: a still unreported association 90
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease 90
Proteinuria: Does vitamin D treatment improve outcomes in CKD? 90
Induction and maintenance treatment of proliferative lupus nephritis: A meta-analysis of randomized controlled trials 89
Prevalence and Correlates of Self-Reported Sexual Dysfunction in CKD: A Meta-analysis of Observational Studies 88
Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials 88
Fluid intake and all-cause mortality, cardiovascular mortality and kidney function: A population-based longitudinal cohort study 88
Antiplatelet agents for chronic kidney disease 88
Antihypertensive agents for preventing diabetic kidney disease 88
Depression and sexual dysfunction in chronic kidney disease: a narrative review of the evidence in areas of significant unmet need 87
Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease 87
IgA Nephropathy: A Disease in Search of a Large-Scale Clinical Trial to Reliably Inform Practice 87
Aldosterone antagonists for preventing the progression of chronic kidney disease 86
null 85
Current structure and organization for renal patient assistance in Italy 84
Aldosterone antagonists for preventing the progression of chronic kidney disease 84
Mesalazine for people with diverticular disease: A systematic review of randomized controlled trials 84
Thyroid hormones for acute kidney injury 83
Associations between hemodialysis access type and clinical outcomes: A systematic review 82
Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir 81
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: A network meta-analysis 81
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients 81
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients 81
Sunset for Statins after AURORA? 80
Antimicrobial agents to prevent peritonitis in peritoneal dialysis: A systematic review of randomized controlled trials 80
Oral disease in adults treated with hemodialysis: prevalence, predictors, and association with mortality and adverse cardiovascular events: the rationale and design of the ORAL Diseases in hemodialysis (ORAL-D) study, a prospective, multinational, longitudinal, observational, cohort study. 80
null 80
Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials 80
Risk of death following kidney allograft failure: A systematic review and meta-analysis of cohort studies 80
null 79
Quality of reporting of randomization methodology in nephrology trials 78
Antiplatelet therapy to prevent hemodialysis vascular access failure: Systematic review and meta-analysis 77
Treatment for peritoneal dialysis-associated peritonitis 76
Patient satisfaction with in-centre haemodialysis care: An International Survey 76
Antihypertensive agents for preventing diabetic kidney disease 75
Home versus in-centre haemodialysis for end-stage kidney disease 75
Pre-emptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients 75
Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy 74
Oral mucosal lesions and risk of all-cause and cardiovascular mortality in people treated with long-term haemodialysis: The ORAL-D multinational cohort study 74
Immunosuppressive treatments for immunoglobulin A nephropathy: A meta-analysis of randomized controlled trials 74
Impact of icodextrin on clinical outcomes in peritoneal dialysis: A systematic review of randomized controlled trials 74
KHA-CARI commentary on the KDIGO clinical practice guideline for lipid management in chronic kidney disease 73
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients 73
HMG CoA reductase inhibitors (statins) for kidney transplant recipients 73
Serum testosterone levels and clinical outcomes in male hemodialysis patients 73
null 72
Darbepoetin for the anaemia of chronic kidney disease 72
Correlation of Treatment Time and Ultrafiltration Rate with Serum Albumin and C-Reactive Protein Levels in Patients with End-Stage Kidney Disease Receiving Chronic Maintenance Hemodialysis: A Cross-Sectional Study 71
HMG CoA reductase inhibitors (statins) for dialysis patients 71
Sevelamer: a promising but unproven drug 71
The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients 71
Sexual Dysfunction in Women with ESRD Requiring Hemodialysis 70
Vitamin D compounds for people with chronic kidney disease requiring dialysis 70
Proteinuria and Clinical Outcomes in Hypertensive Patients 69
Antihypertensive agents for primary prevention of diabetic nephropathy 69
Vitamin D compounds for people with chronic kidney disease not requiring dialysis 69
Biocompatible dialysis fluids for peritoneal dialysis 69
The beliefs and expectations of patients and caregivers about home haemodialysis: An interview study 69
Meta-analysis: Vitamin D compounds in chronic kidney disease 69
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients 69
Haemoglobin targets: we were wrong, time to move on 68
How to conduct a randomized trial 68
Robotic Versus Laparoscopic Minimally Invasive Surgery for Rectal Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials 68
Prevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studies. 68
Patients' perspectives on hemodialysis vascular access: A systematic review of qualitative studies 68
Non-immunosuppressive treatment for IgA nephropathy 68
Healthy dietary patterns and risk of mortality and ESRD in CKD: A meta-analysis of cohort studies 67
Calcimimetics and other simple pharmacological interventions do not work in dialysis: What can we do about it? 67
Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes (LIRICO) randomized trial 66
The Italian experience of the national registry of renal biopsies 66
Effects of intensive blood pressure lowering on the progression of chronic kidney disease: A systematic review and meta-analysis 66
null 66
Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: A cross-sectional analytic study 65
null 65
Benefits and Harms of Phosphate Binders in CKD: A Systematic Review of Randomized Controlled Trials 65
null 65
null 64
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease 63
Treatment for peritoneal dialysis-associated peritonitis 63
null 63
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis 62
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis 62
null 61
null 61
null 61
Totale 7.988
Categoria #
all - tutte 81.884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.884


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.311 0 0 0 0 866 637 784 962 956 532 282 292
2020/20213.002 128 475 162 385 326 155 120 390 90 434 149 188
2021/20222.410 186 357 20 80 112 152 116 88 124 115 185 875
2022/20233.106 443 347 277 304 273 329 25 440 454 21 138 55
2023/20241.117 84 186 77 28 103 304 30 126 18 28 16 117
2024/2025803 44 73 394 171 121 0 0 0 0 0 0 0
Totale 17.855